GLA and Fabry disease: Fabry disease (FD) results from pathogenic galactosidase A (GLA) variants, leading to a deficiency in lysosomal α-galactosidase A (α-Gal A) and accumulation of the sphingolipid globotriaosylceramide (Gb3).